roxatidine acetate has been researched along with Coronary Disease in 1 studies
roxatidine acetate: structure given in first source
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halabi, A | 1 |
| Nokhodian, A | 1 |
| Kirch, W | 1 |
1 trial available for roxatidine acetate and Coronary Disease
| Article | Year |
|---|---|
Haemodynamic effects of roxatidine, an H2-receptor antagonist.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Electrocardiography; Heart Fa | 1992 |